Becton Dickinson and Company

253.18-0.6400-0.25%Vol 876.78K1Y Perf 14.60%
Sep 24th, 2021 16:00 DELAYED
BID249.84 ASK254.76
Open253.22 Previous Close253.82
Pre-Market- After-Market253.18
 - -  - -%
Target Price
270.45 
Analyst Rating
Moderate Buy 2.00
Potential %
6.82 
Finscreener Ranking
+     38.56
Insiders Trans % 3/6/12 mo.
-100/-100/-100 
Value Ranking
     40.03
Insiders Value % 3/6/12 mo.
-100/-100/-100 
Growth Ranking
★★     45.77
Insiders Shares Cnt. % 3/6/12 mo.
-100/-100/-100 
Income Ranking
     32.86
Price Range Ratio 52W %
70.36 
Earnings Rating
Sell
Market Cap72.71B 
Earnings Date
4th Nov 2021
Alpha-0.00 Standard Deviation0.06
Beta0.76 

Today's Price Range

252.44254.61

52W Range

219.50267.37

5 Year PE Ratio Range

35.80648.50

Summary:

Neutral

Technical Indicators: Neutral
Moving Averages: Buy
Performance
1 Week
-3.35%
1 Month
2.50%
3 Months
4.97%
6 Months
4.74%
1 Year
14.60%
3 Years
-3.43%
5 Years
41.05%
10 Years
272.81%

TickerPriceChg.Chg.%
BDX253.18-0.6400-0.25
AAPL146.920.09000.06
GOOG2 852.6616.13000.57
MSFT299.35-0.2100-0.07
XOM57.590.51000.89
WFC47.920.12000.25
JNJ164.36-0.5000-0.30
FB352.967.00002.02
GE103.800.84000.82
JPM163.041.86001.15
Financial StrengthValueIndustryS&P 500US Markets
0.70
1.20
0.39
0.73
5.40
Leverage Ratio 2.20
ProfitabilityValueIndustryS&P 500US Markets
47.00
13.10
24.30
7.30
9.83
RevenueValueIndustryS&P 500US Markets
19.90B
69.28
6.55
9.84
DividendsValueIndustryS&P 500US Markets
1.28
3.32
2.70
4.05
Payout ratio57.00
Earnings HistoryEstimateReportedSurprise %
Q03 20212.462.7411.38
Q02 20213.043.194.93
Q01 20213.144.5544.90
Q04 20202.502.7911.60
Q03 20202.052.207.32
Q02 20202.282.5511.84
Q01 20202.632.650.76
Q04 20193.303.310.30
Earnings Per EndEstimateRevision %Trend
9/2021 QR2.42-7.28Negative
9/2021 FY12.900.70Positive
12/2021 QR2.90-10.22Negative
9/2022 FY12.34-5.66Negative
Next Report Date4th Nov 2021
Estimated EPS Next Report2.42
Estimates Count10
EPS Growth Next 5 Years %8.30
Volume Overview
Volume876.78K
Shares Outstanding287.19M
Shares Float284.99M
Trades Count17.84K
Dollar Volume390.86M
Avg. Volume1.36M
Avg. Weekly Volume1.25M
Avg. Monthly Volume1.41M
Avg. Quarterly Volume1.30M

Becton Dickinson and Company (NYSE: BDX) stock closed at 253.18 per share at the end of the most recent trading day (a -0.25% change compared to the prior day closing price) with a volume of 928.28K shares and market capitalization of 72.71B. Is a component of S&P 500, Russell 1000 indices and it is traded on NYSE exchange. The company belongs in the Medical Devices & Instruments industry, Healthcare sector and employs 72000 people. Becton Dickinson and Company CEO is Thomas E. Polen.

The one-year performance of Becton Dickinson and Company stock is 14.6%, while year-to-date (YTD) performance is 1.18%. BDX stock has a five-year performance of 41.05%. Its 52-week range is between 219.5 and 267.37, which gives BDX stock a 52-week price range ratio of 70.36%

Becton Dickinson and Company currently has a PE ratio of 41.30, a price-to-book (PB) ratio of 3.12, a price-to-sale (PS) ratio of 3.74, a price to cashflow ratio of 14.80, a PEG ratio of 2.32, a ROA of 3.35%, a ROC of 5.44% and a ROE of 7.54%. The company’s profit margin is 9.83%, its EBITDA margin is 24.30%, and its revenue ttm is $19.90 Billion , which makes it $69.28 revenue per share.

Of the last four earnings reports from Becton Dickinson and Company, there were 4 positive earnings surprise and 0 negative earnings surprise. The company has EPS estimate of $2.42 for the next earnings report. Becton Dickinson and Company’s next earnings report date is 04th Nov 2021.

The consensus rating of Wall Street analysts for Becton Dickinson and Company is Moderate Buy (2), with a target price of $270.45, which is +6.82% compared to the current price. The earnings rating for Becton Dickinson and Company stock is Sell (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

Becton Dickinson and Company has a dividend yield of 1.28% with a dividend per share of $3.32 and a payout ratio of 57.00%.

Becton Dickinson and Company has a Neutral technical analysis rating based on Technical Indicators (ADX : 9.34, ATR14 : 3.63, CCI20 : -70.17, Chaikin Money Flow : 0.02, MACD : 1.59, Money Flow Index : 48.11, ROC : -3.69, RSI : 45.03, STOCH (14,3) : 6.40, STOCH RSI : 0.00, UO : 36.48, Williams %R : -93.60), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of Becton Dickinson and Company in the last 12-months were: Claire M. Fraser-Liggett (Sold 387 shares of value $97 361 ), James Lim (Option Excercise at a value of $1 964 902), James Lim (Sold 6 956 shares of value $1 790 752 ), Rebecca W. Rimel (Sold 1 658 shares of value $424 854 ), Roland Goette (Option Excercise at a value of $267 090), Roland Goette (Sold 930 shares of value $213 993 ), Thomas Spoerel (Sold 266 shares of value $64 452 )

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
7 (46.67 %)
7 (46.67 %)
7 (43.75 %)
Moderate Buy
1 (6.67 %)
1 (6.67 %)
1 (6.25 %)
Hold
7 (46.67 %)
7 (46.67 %)
8 (50.00 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Summary RatingModerate Buy
2.00
Moderate Buy
2.00
Moderate Buy
2.06

Becton Dickinson and Company

Becton, Dickinson is the world's largest manufacturer and distributor of medical surgical products, such as needles, syringes, and sharps-disposal units. The company also manufactures diagnostic instruments and reagents, as well as flow cytometry and cell-imaging systems. BD Interventional (largely the former Bard business) accounts for 23% of revenue. International revenue accounts for 44% of the company's business.

CEO: Thomas E. Polen

Telephone: +1 201 847-6800

Address: 1 Becton Drive, Franklin Lakes 07417-1880, NJ, US

Number of employees: 72 000

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

60%40%

Bearish Bullish

61%39%

Bearish Bullish

64%36%

TipRanks News for BDX

News

Stocktwits